1. Bellerophon Therapeutics Appoints Mary Ann Cloyd as an Independent Board Member

    Bellerophon Therapeutics Appoints Mary Ann Cloyd as an Independent Board Member

    WARREN, N.J.-- Bellerophon Therapeutics, Inc., a clinical-stage biotherapeutics company, today announced the appointment of Mary Ann Cloyd as an independent director. Cloyd will also serve ...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Topics Mentioned